Harbourvest Partners LLC Voyager Therapeutics, Inc. Transaction History

Harbourvest Partners LLC

  • $188 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$6.0 - $10.78 $370,656 - $665,945
61,776 New
61,776 $476,000
Q1 2019

May 13, 2019
SELL
$8.0 - $19.66 $581,808 - $1.43 Million
-72,726 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$17.11 - $21.74 $1.24 Million - $1.58 Million
72,726 New
72,726 $1.38 Million

Others Institutions Holding VYGR

# of Institutions
130
Shares Held
34.7M
Call Options Held
39.7K
Put Options Held
34.6K
View Full List

About Voyager Therapeutics, Inc.

VYGR Quotes by TradingView
  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $223M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Harbourvest Partners LLC Portfolio

Follow Harbourvest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbourvest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbourvest Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email